Skip to Content

Lifeline Biotechnologies Inc LLBO

Morningstar Rating
$0.00 0.00 (73.33%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

LLBO is trading at a 348% premium.
Price
$0.00
Fair Value
$7.96
Uncertainty
Extreme
1-Star Price
$1.84
5-Star Price
$8.44
Economic Moat
Vdpc
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if LLBO is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.25
Market Cap
$1.26 Mil
Volume/Avg
320,000 / 432,699

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Lifeline Biotechnologies Inc is an US-based company engaged in the business of developing and marketing technology, applications, medical devices and procedural techniques for the screening, diagnosis, treatment and management of disease and medical conditions. It has developed, tested, and patented a process that assists in the identification of dense breast tissue. The process is to be targeted as a screening protocol assisting in the early detection of breast tissue abnormalities and breast cancers.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Total Number of Employees

Valuation

Metric
LLBO
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
LLBO
Quick Ratio
Current Ratio
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
LLBO
Return on Assets (Normalized)
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesTymydvpzyDphbsyn$182.4 Bil
SYK
Stryker CorpBmpnqdlwRhvyp$127.5 Bil
MDT
Medtronic PLCXctsdsksyBcchpb$113.7 Bil
BSX
Boston Scientific CorpDqnrrtbpDkspp$109.6 Bil
EW
Edwards Lifesciences CorpSmjjzzmjRdwkz$54.3 Bil
DXCM
DexCom IncFrfvvmlgwbCmwy$52.2 Bil
PHG
Koninklijke Philips NV ADRKqsycscKtmcpg$25.9 Bil
ZBH
Zimmer Biomet Holdings IncRrcqmxfbnpMfp$24.9 Bil
ALGN
Align Technology IncSccbbscSkmdg$20.6 Bil
SNN
Smith & Nephew PLC ADRHqkkfqmXtzmts$11.4 Bil

Sponsor Center